Record quarterly revenue and profits were driven by broad-based growth across key practices, with Life Sciences, Energy, and Antitrust & Competition Economics leading. Raised full-year guidance reflects strong demand, robust pipeline, and continued investments in talent.Based on CRA International,I…
Revenue grew 12.8% year-over-year in Q2 2026, with net income up to $13.5 million and diluted EPS at $2.10. A new $400 million credit facility was established, and share repurchases and dividends continued. Cash and liquidity remain strong for ongoing operations.Original document: CRA International…
Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced financial results for the fiscal second quarter ended July 4, 2026.“Continued momentum in the business and demand for our services drove CRA’s quarterly r…
Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced an increase and extension to its existing credit facility with a bank syndicate comprised of six lenders. The five-year credit facility is for an aggrega…
Economic consulting firm CRA International NASDAQ:CRAI will be announcing earnings results this Thursday before market hours. Here’s what to expect.CRA beat analysts’ revenue expectations last quarter, reporting revenues of $201 million, up 10.5% year on year. It was a satisfactory quarter for the…
PHILADELPHIA and VANCOUVER, British Columbia, July 07, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. NASDAQ:BCTX, BCTXL) TSX:BCT (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced that it has engage…
